Skip to main contentSkip to main content
The Science

FDA Approval and Safety Standards for Orthokeratology Lenses

DJ
Dr. James Singletary, OD, FIAOMCOD, FIAOMC
January 5, 2026
9 min read
Clinically Reviewed  ·  March 2026
Reviewed by Dr. James Singletary, OD, FIAOMC
FDA Approval and Safety Standards for Orthokeratology Lenses

Article Title: FDA Approval and Safety Standards for Orthokeratology Lenses

ARTICLE: As an optometrist who has dedicated my career to fighting childhood myopia, I’ve had the privilege of helping countless families in Fayetteville and across Cumberland County discover the life-changing benefits of orthokeratology. It’s a technology I’m deeply passionate about, not just for its ability to provide clear vision without daytime glasses or contacts, but for its proven effectiveness in myopia control. But with any medical treatment, especially one for our children, the first question is always—and rightly so—"Is it safe?"

I hear it from parents every day. They’ve heard about ortho-k, maybe from a friend or through their own research, and they’re intrigued. The idea of their child being free from glasses, especially for sports and swimming, is incredibly appealing. But the thought of a contact lens worn overnight can be intimidating. That’s why I want to pull back the curtain and talk about the single most important factor in ensuring the safety and efficacy of ortho-k: FDA approval.

In This Article


What FDA Approval Means for Your Family’s Safety

So, what does it really mean when we say an ortho-k lens is "FDA-approved"? The U.S. Food and Drug Administration (FDA) is the federal agency responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. And yes, contact lenses, including ortho-k lenses, are classified as medical devices.

For a device to earn FDA approval, it must go through a rigorous, multi-year process of scientific and clinical review. The manufacturer has to provide extensive data from laboratory studies and human clinical trials to prove two fundamental things:

  1. It is safe: The device does not pose an unreasonable risk of illness or injury.
  2. It is effective: The device performs as promised and delivers a real clinical benefit.

This isn’t just about paperwork. It’s about a deep, scientific evaluation of the device’s design, materials, manufacturing processes, and performance in real patients. The FDA’s review is exhaustive, and their standards are among the highest in the world. When you choose an FDA-approved ortho-k lens, you’re not just getting a piece of plastic; you’re getting a medical device that has been scrutinized, tested, and validated to meet stringent safety and performance benchmarks. It’s a seal of approval that provides peace of mind, and frankly, it’s a non-negotiable for me as a practitioner.

Think of it like this: you wouldn’t give your child a medication that wasn’t approved by the FDA. The same standard should apply to anything you put in their eyes. This approval is the bedrock of patient safety in the world of orthokeratology.

A Landmark Achievement: The History of FDA Approval for Myopia Control

Ortho-k's journey to becoming a trusted option for myopia management is marked by key FDA milestones. Previously, it was an "off-label" treatment, lacking the safety assurances of formal FDA approval.

In 2002, the FDA cleared Paragon CRT®, the first lens specifically for overnight orthokeratology. This validated the treatment as a safe and effective method for vision correction.

Euclid's Emerald™ lens followed in 2004, and other designs have since been approved, further establishing the safety of overnight orthokeratology.

Here is a look at some of the leading FDA-approved ortho-k lenses available in the United States today:

Chart of FDA-Approved Ortho-K Lenses

This chart showcases some of the most trusted and widely used FDA-approved orthokeratology lens designs in the U.S. market.

This history demonstrates a commitment to safety and innovation, transforming ortho-k into a powerful tool for myopia management.

Behind the Approval: The Rigorous Testing Process

The FDA approval process is a marathon, involving several stages of scrutiny.

Pre-clinical studies test the lens material's oxygen permeability, durability, and resistance to deposits. Computer simulations model the lens's interaction with the cornea.

A scientist in a quality control lab inspecting a contact lens.

In state-of-the-art labs like this one, every aspect of an ortho-k lens is meticulously tested to ensure it meets the highest standards for safety and quality before it ever reaches a patient’s eye.

Successful pre-clinical data leads to human clinical trials involving hundreds of patients. Investigators monitor patients closely over an extended period.

During these trials, we collect a mountain of data on:

  • Efficacy: Does the lens successfully reduce myopia and provide clear vision throughout the day?
  • Safety: Are there any adverse events, such as inflammation, infection, or corneal staining? How does the eye health of the trial participants compare to a control group?
  • Fit and Comfort: How well does the lens fit on a variety of corneal shapes? Is it comfortable for overnight wear?

The comprehensive data is submitted to the FDA for review by a team of experts. Approval is granted only when the benefits are proven to outweigh the risks.

Post-Market Surveillance: The Safety Watch Doesn’t End

FDA clearance isn't the end of the safety story. Post-market surveillance is a critical phase where the FDA continues to monitor the performance of lenses and manufacturers must report any serious adverse events.

This feedback loop allows the FDA to take action if issues arise, from updating labels to recalling products, forming a crucial safety net for patients.

Parents often ask about infection risks. While all contact lenses carry some risk, studies show that with proper hygiene, the risk of microbial keratitis with FDA-approved ortho-k lenses is very low and comparable to other overnight lenses.

Let’s look at the data:

Chart comparing adverse event rates of different contact lens types.

This chart compares the estimated incidence of microbial keratitis, a rare but serious complication, across different types of contact lenses. As you can see, the rate for ortho-k is similar to other approved overnight modalities and remains very low overall. [1]

For parents, this means that FDA-approved ortho-k has a strong safety profile. Minimizing risk comes down to choosing an experienced provider and following care instructions diligently. At our Fort Liberty area clinic, we prioritize patient education to ensure every family is confident in their lens care routine.

How to Verify Your Lenses are FDA-Approved

You have the right to know what device is being used. To ensure you're getting an FDA-approved lens, simply ask your doctor.

A reputable practitioner will readily provide the brand and design of the lens and confirm its FDA approval. You can also check the packaging for the FDA label.

Here’s a quick comparison of some of the leading FDA-approved ortho-k lens brands available today:

Lens BrandManufacturerYear of FDA ApprovalKey Features
Paragon CRT®CooperVision Specialty EyeCare2002The first FDA-approved overnight ortho-k lens; widely used with a long track record of success.
Euclid Emerald™Euclid Systems Corporation2004Known for its advanced lens design software and customization options.
BE-RetainerBausch + Lomb2021A more recent addition, offering advanced material technology for high oxygen permeability.
GOV® (
Free Download

Free Download: The Science Behind Ortho-K

A plain-language summary of 12 key clinical studies on orthokeratology efficacy.

  • Summary of 12 peer-reviewed clinical studies
  • Myopia progression rates with/without treatment
  • Ortho-K vs. atropine vs. multifocal lenses
  • FDA approval history and safety data

No spam. Unsubscribe anytime. We respect your privacy.

DJ

Dr. James Singletary, OD, FIAOMC

Dr. James Singletary, OD, FIAOMC is a licensed optometrist and orthokeratology specialist with over 15 years of clinical experience in myopia control, myopia management, orthokeratology, and nonsurgical vision correction. He is the founder of Eye Medics Optometry in Fayetteville, NC and the creator of the sleepSEE ortho-k program.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified eye care professional for diagnosis and treatment of eye conditions. The information provided here should not be used as a substitute for professional medical advice.

Share This Article